Oncosil Medical Ltd has released a press release.
UK Central Ethics Approval
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from OncoSil Medical
- First subject recruited
- Appendix 4D & Half Year Accounts
- MHRA Approval to commence study in UK
- Ethics Approval for OncoPac Clinical Study
- Appendix 4C - Quarterly Cash Flow
Later from OncoSil Medical
- US IRB Approval, MD Anderson Cancer Centre
- Specialised Therapeutics Australia supporting OncoSil study
- First OncoSil Device Implantation procedure completed
- Appendix 4C and Quarterly update
- Second subject recruited at Monash Health Melbourne
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical